← Dolby Laboratories, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.0b |
$1.1b
+5.43%
|
$1.2b
+8.37%
|
$1.2b
+5.95%
|
$1.2b
-6.43%
|
$1.3b
+10.28%
|
$1.3b
-2.14%
|
$1.3b
+3.66%
|
$1.3b
-2.00%
|
$1.3b
+5.92%
|
$1.4b
+0.39%
|
|
| Cost of Goods and Services Sold | $109.0m |
$118.3m
+8.56%
|
$128.3m
+8.41%
|
$160.9m
+25.41%
|
$146.5m
-8.92%
|
$130.0m
-11.24%
|
$141.4m
+8.72%
|
$152.6m
+7.93%
|
$140.5m
-7.91%
|
$160.1m
+13.98%
|
$167.8m
+4.77%
|
|
| Gross Profit | $916.8m |
$963.1m
+5.06%
|
$1.0b
+8.36%
|
$1.1b
+3.55%
|
$1.0b
-6.06%
|
$1.2b
+13.39%
|
$1.1b
-3.37%
|
$1.1b
+3.12%
|
$1.1b
-1.22%
|
$1.2b
+4.92%
|
$1.2b
-0.20%
|
|
| Interest Income (Expense), Net | — | — | — | — | — | — | — | $28.1m |
$34.1m
+21.33%
|
$15.4m
-54.88%
|
— | |
| Research and Development Expense | $219.6m | $233.3m | $236.8m | $237.9m | $239.0m | $253.6m | $261.2m | $271.5m | $263.7m | $261.8m | $265.9m | |
| Selling and Marketing Expense | $295.3m | $296.7m | $309.8m | $343.8m | $335.9m | $332.7m | $358.7m | $354.4m | $334.5m | $360.7m | $658.8m | |
| General and Administrative Expense | $168.9m | $171.7m | $197.5m | $205.4m | $219.8m | $224.2m | $275.3m | $258.5m | $270.4m | $286.5m | $295.5m | |
| Amortization of Intangible Assets | $33.2m | $30.9m | $26.5m | $29.7m | $29.5m | $29.5m | $29.0m | $28.6m | $33.2m | $45.3m | — | |
| Operating Expenses | $685.0m | $714.5m | $743.7m | $823.7m | $796.6m | $806.8m | $905.8m | $931.4m | $874.9m | $924.0m | $924.7m | |
| Operating Income (Loss) | $231.8m |
$248.6m
+7.26%
|
$300.0m
+20.66%
|
$257.1m
-14.31%
|
$218.7m
-14.91%
|
$344.4m
+57.44%
|
$206.6m
-40.01%
|
$215.8m
+4.43%
|
$258.3m
+19.73%
|
$265.0m
+2.57%
|
$261.8m
-1.18%
|
|
| Interest Expense | $125k | $127k | $198k | $170k | $186k | $479k | $394k | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($1.4m) | ($1.4m) | ($5.9m) | $481k | $8.4m | $7.1m | $2.5m | $6.2m | $20.1m | $23.1m | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $5.0m | $5.1m | $14.2m | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $37.2m | $28.2m | $75.7m | $60.5m | $32.4m | $104.7m | $33.3m | $44.1m | $89.5m | $102.9m | $276.8m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $354.5m | $215.3m | $250.1m | $312.5m | $303.5m | $276.8m | |
| Current Income Tax Expense (Benefit) | $72.2m | $86.9m | $100.3m | $78.9m | $13.4m | $73.7m | $60.8m | $66.7m | $69.8m | $42.0m | $48.8m | |
| Income Tax Expense (Benefit) | $49.5m | $54.2m | $190.1m | $26.8m | $8.1m | $36.7m | $31.4m | $48.4m | $48.2m | $47.0m | $48.8m | |
| Net Income (Loss) Attributable to Parent | $185.9m |
$201.8m
+8.58%
|
$122.2m
-39.42%
|
$255.2m
+108.72%
|
$231.4m
-9.32%
|
$310.2m
+34.09%
|
$184.1m
-40.66%
|
$200.7m
+9.00%
|
$261.8m
+30.48%
|
$255.0m
-2.60%
|
$226.2m
-11.31%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $542k | $625k | $559k | $354k | $256k | $7.6m | ($189k) | — | — | — | $226.2m | |
| Earnings Per Share, Basic | $1.85 | $1.98 | $1.18 | $2.51 | $2.30 | $3.07 | $1.84 | $2.10 | $2.74 | $2.66 | $2.38 | |
| Earnings Per Share, Diluted | $1.81 | $1.95 | $1.14 | $2.44 | $2.25 | $2.97 | $1.81 | $2.05 | $2.69 | $2.62 | $2.35 | |
| Common Stock, Dividends, Per Share, Declared | $0.50 | $0.58 | $0.67 | $0.79 | $0.88 | $0.91 | $1.02 | $1.11 | $1.23 | $1.32 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 100.7m | 101.8m | 103.4m | 101.6m | 100.6m | 101.2m | 100.0m | 95.8m | 95.5m | 95.9m | 95.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | 102.4m | 103.3m | 107.0m | 104.6m | 102.9m | 104.6m | 102.0m | 97.7m | 97.3m | 97.5m | 96.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.